Retrospective study shows improved progression-free survival in de novo metastatic nasopharyngeal carcinoma patients receiving chemo-immunotherapy.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
He et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: